A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations
Authors:
- Katerina A. VardulakiKVKaterina A. Vardulaki
- Christopher ConlonCCChristopher Conlon
- Jonathan CookeJCJonathan Cooke
- Pascual Daza-RamirezPDPascual Daza-Ramirez
- E.GLyn V. EvansEEE.GLyn V. Evans
- Peter M. HawkeyPHPeter M. Hawkey
- Raoul HerbrechtRHRaoul Herbrecht
- David I. MarksDMDavid I. Marks
- Jose M. MoraledaJMJose M. Moraleda
- Gilbert R. ParkGPGilbert R. Park
- Stephen J. SennSSStephen J. Senn
- 1 May 2003
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 25 (5) , 1295-1320
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Correlates of acute renal failure in patients receiving parenteral amphotericin BKidney International, 2001
- Comparison of Amphotericin B Lipid Complex (ABLC) vs. AmBisome in the Treatment of Suspected or Documented Fungal Infections in Patients with LeukemiaLeukemia & Lymphoma, 2001
- A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile NeutropeniaClinical Infectious Diseases, 2000
- Management of fungal infections in neutropenic patients: more doubts than certainties?International Journal of Antimicrobial Agents, 2000
- Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and NeutropeniaNew England Journal of Medicine, 1999
- Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled studyBone Marrow Transplantation, 1999
- Do variations in molecular structure affect the clinical efficacy and safety of lipid-based amphotericin B preparations?Leukemia Research, 1997
- Invasive Fungal Infections in Liver Transplant Recipients Receiving Tacrolimus as the Primary Immunosuppressive AgentClinical Infectious Diseases, 1997
- Liposomal amphotericin B (AmBisome) reduces dissemination of infection ad compared with amphotericin B deoxycholate (Fungizone) in a rat model of pulmonary aspergillosisJournal of Antimicrobial Chemotherapy, 1996
- LIPOSOMAL AMPHOTERICIN B PREVENTS INVASIVE FUNGAL INFECTIONS IN LIVER TRANSPLANT RECIPIENTSTransplantation, 1995